Free daily newsletter. No spam. Unsubscribe anytime.

Capsul is a daily brief for pharma and biotech professionals. One edition lands in your inbox every weekday morning, covering what moved, why it matters, and what to watch.

The week has a rhythm: 

Monday sets up the week and reads what moved over the last one.
Tuesday goes inside the trial data: what it says against what the company claimed. 
Wednesday takes on the regulators, the FDA, EMA, and MHRA.
Thursday goes deep on one therapeutic area.
Friday steps back for the longer view. 

Join and you'll stay on top of what matters in a few minutes a day.